CPC Subgroup
C12Y 104/01 with NAD+ or NADP+ as acceptor (1.4.1)
Full Title
Oxidoreductases acting on the CH-NH2 group of donors (1.4) > with NAD+ or NADP+ as acceptor (1.4.1)
22 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 104/01001 Alanine dehydrogenase (1.4.1.1)
- C12Y 104/01002 Glutamate dehydrogenase (1.4.1.2)
- C12Y 104/01003 Glutamate dehydrogenase (NAD(P)+)(1.4.1.3)
- C12Y 104/01004 Glutamate dehydrogenase (NADP+) (1.4.1.4)
- C12Y 104/01005 L-Amino-acid dehydrogenase (1.4.1.5)
- C12Y 104/01007 Serine 2-dehydrogenase (1.4.1.7)
- C12Y 104/01008 Valine dehydrogenase (NADP+) (1.4.1.8)
- C12Y 104/01009 Leucine dehydrogenase (1.4.1.9)
- C12Y 104/0101 Glycine dehydrogenase (1.4.1.10)
- C12Y 104/01011 L-Erythro-3,5-diaminohexanoate dehydrogenase (1.4.1.11)
- C12Y 104/01012 2,4-Diaminopentanoate dehydrogenase (1.4.1.12)
- C12Y 104/01013 Glutamate synthase (NADPH) (1.4.1.13)
- C12Y 104/01014 Glutamate synthase (NADH) (1.4.1.14)
- C12Y 104/01015 Lysine dehydrogenase (1.4.1.15)
- C12Y 104/01016 Diaminopimelate dehydrogenase (1.4.1.16)
- C12Y 104/01017 N-Methylalanine dehydrogenase (1.4.1.17)
- C12Y 104/01018 Lysine 6-dehydrogenase (1.4.1.18)
- C12Y 104/01019 Tryptophan dehydrogenase (1.4.1.19)
- C12Y 104/0102 Phenylalanine dehydrogenase (1.4.1.20)
- C12Y 104/01021 Aspartate dehydrogenase (1.4.1.21)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692